This is an observational trial planned to study the levels of biomarkers like bio-ADM and penKid to understand their role in predicting the clinical outcomes of cardiac surgical patients requiring Intra-Aortic Balloon Pump support.
Not Applicable
- Conditions
- Health Condition 1: 5- Extracorporeal or Systemic Assistance and Performance
- Registration Number
- CTRI/2023/01/049047
- Lead Sponsor
- Rivaara Labs Pvt. Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Above18 years of age and of either sex
2. Patients with following indications Left Ventricular Dysfunction/Left Ventricular Failure/Recent Myocardial Infarction/Unstable Angina/Critical Coronary Artery Disease/Left Main Coronary Artery Disease
Exclusion Criteria
1. Patients aged below 18 years
2. Pregnant or lactating mothers
3. Terminal stage disease
4. Patients with conditions like
• Aortic regurgitation
• Aortic dissection
• Chronic end-stage heart disease with no anticipation of recovery
• Aortic stents
• Uncontrolled sepsis
• Uncontrolled bleeding diathesis
• Moderate to severe aortic regurgitation
• An aortic aneurysm or aortic dissection
Severe peripheral artery disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method eed for vasopressors and therapy modifications as appropriate.Timepoint: 07 Days
- Secondary Outcome Measures
Name Time Method All cause ICU mortality, length of ICU stay, need for Renal Replacement Therapy and mechanical ventilation.Timepoint: 07 Days